#Industry News
Nature Reports Breakthrough in Broad-Spectrum H5 Influenza Vaccine
Antigenic cartography served as a tool for identifying optimal vaccine antigens.
Highly pathogenic avian influenza A(H5) viruses remain a serious global health concern. They affect wild and domestic birds and are increasingly spilling over into mammals, including humans. Rapid antigenic changes make vaccine development and pandemic preparedness challenging, as traditional methods struggle to keep pace with emerging variants. To overcome this, researchers are developing innovative vaccine strategies aimed at delivering broad protection across the diverse antigenic landscape of A(H5) viruses.